Suppr超能文献

心力衰竭患者的肾功能监测——最佳频率是多少?一篇综述。

Renal function monitoring in heart failure - what is the optimal frequency? A narrative review.

机构信息

The Wolfson Centre for Personalised Medicine, The University of Liverpool, Liverpool, UK.

Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, UK.

出版信息

Br J Clin Pharmacol. 2018 Jan;84(1):5-17. doi: 10.1111/bcp.13434. Epub 2017 Oct 22.

Abstract

The second most common cause of hospitalization due to adverse drug reactions in the UK is renal dysfunction due to diuretics, particularly in patients with heart failure, where diuretic therapy is a mainstay of treatment regimens. Therefore, the optimal frequency for monitoring renal function in these patients is an important consideration for preventing renal failure and hospitalization. This review looks at the current evidence for optimal monitoring practices of renal function in patients with heart failure according to national and international guidelines on the management of heart failure (AHA/NICE/ESC/SIGN). Current guidance of renal function monitoring is in large part based on expert opinion, with a lack of clinical studies that have specifically evaluated the optimal frequency of renal function monitoring in patients with heart failure. Furthermore, there is variability between guidelines, and recommendations are typically nonspecific. Safer prescribing of diuretics in combination with other antiheart failure treatments requires better evidence for frequency of renal function monitoring. We suggest developing more personalized monitoring rather than from the current medication-based guidance. Such flexible clinical guidelines could be implemented using intelligent clinical decision support systems. Personalized renal function monitoring would be more effective in preventing renal decline, rather than reacting to it.

摘要

在英国,因药物不良反应而住院的第二大常见原因是利尿剂引起的肾功能障碍,特别是在心力衰竭患者中,利尿剂治疗是治疗方案的主要手段。因此,对于这些患者,监测肾功能的最佳频率是预防肾衰竭和住院的重要考虑因素。这篇综述根据心力衰竭管理的国家和国际指南(AHA/NICE/ESC/SIGN),查看了心力衰竭患者肾功能监测的最佳实践的现有证据。目前肾功能监测的指南在很大程度上基于专家意见,缺乏专门评估心力衰竭患者肾功能监测最佳频率的临床研究。此外,指南之间存在差异,建议通常不具体。为了更安全地联合使用利尿剂和其他抗心力衰竭治疗药物,需要更好的肾功能监测频率证据。我们建议制定更个性化的监测方案,而不是基于目前的药物指导。可以使用智能临床决策支持系统来实施这种灵活的临床指南。个性化的肾功能监测在预防肾功能下降方面更有效,而不是在肾功能下降后再进行反应。

相似文献

引用本文的文献

4
Baseline Characteristics of the DISCOVER CKD Prospective Cohort.DISCOVER慢性肾脏病前瞻性队列的基线特征。
Adv Ther. 2025 Mar;42(3):1393-1418. doi: 10.1007/s12325-024-03028-z. Epub 2024 Nov 29.

本文引用的文献

10
Loop Diuretics in Clinical Practice.临床实践中的袢利尿剂
Electrolyte Blood Press. 2015 Jun;13(1):17-21. doi: 10.5049/EBP.2015.13.1.17. Epub 2015 Jun 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验